Vaxart receives Nasdaq delisting notice after withdrawing reverse stock split

Vaxart, Inc.

On Sept 19, 2025, Nasdaq notified Vaxart that its securities will be delisted due to noncompliance with the Panel's conditions.
The company withdrew its reverse stock split proposal on Sept 18, 2025, failing a key condition for continued listing.
Trading on Nasdaq was suspended since July 8, 2025; VXRT now trades on OTCQX Best Market.
The Panel had required shareholder approval of a reverse split by Sept 5, 2025, and completion by Oct 6, 2025.
No further Nasdaq listing appeal is indicated; stock continues trading OTC under symbol VXRT.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.